Clinical Trial Update: A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain [Phase 3]

View source ↗

Summary

Pfizer completed a Phase 3 study of ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride) in adults with moderate to severe chronic low back pain, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain
• Pain

Drugs mentioned

• ALO-02 (oxycodone/naloxone)

Snippet

Sponsor: Pfizer | Conditions: Chronic Pain, Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2017-04-04